Home › Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly
 

Keywords :   


Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly

2015-02-11 03:12:04| Biotech - Topix.net

Bothell-based biotech Seattle Genetics , which develops cancer treatments, posted a $27 million loss on revenue of $74 million in its fourth quarter earnings today. While the company's overall sales of $74 million in the fourth quarter increased from $67 million in fourth quarter 2013, its losses also increased to $27 million from $15.7 million during the same quarter a year ago.

Tags: up stock lead loss

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Trump tariffs could cost UK 22bn of exports
08.11Watchdog to review police handling of Al Fayed abuse claims
08.11Cattle marketing: Its about making the right decisions
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
08.11Statement from the U.S. Green Building Council on the 2024 Election Results
08.11Bolt drivers win right to holiday and minimum wage
08.11INX details acquisition, SpectraGraphics grows and more
More »